Investigation for Long-Term Investors in Shares of Stemline Therapeutics Inc (STML) Announced
An investigation on behalf of current long-term investors in shares of Stemline Therapeutics Inc (NASDAQ:STML) concerning potential breaches of fiduciary duties by certain directors and officers of Stemline Therapeutics Inc was announced.
View full press release